Photo by imonnet from unsplash
The American Academy of Pediatrics Subcommittee on Hyperbilirubinemia acknowledged the fact that there is no standard for discontinuing phototherapy.1 For infants who are readmitted after birth, it recommends that phototherapy… Click to show full abstract
The American Academy of Pediatrics Subcommittee on Hyperbilirubinemia acknowledged the fact that there is no standard for discontinuing phototherapy.1 For infants who are readmitted after birth, it recommends that phototherapy may be discontinued when the total serum bilirubin level (TSB) falls to <13 to 14 mg/dL (239–239 μmol/L).1 On the basis of a huge cohort of newborns treated for hyperbilirubinemia, Chang et al2 thankfully provided an evidence-based prediction tool (score) to help clinicians decide when … E-mail: korsche{at}kliniken-koeln.de
Journal Title: Pediatrics
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!